COMPARATIVE PHARMACOKINETICS OF 2 DIASTEREOISOMERS DEXAMETHASONE AND BETAMETHASONE IN PLASMA AND CEREBROSPINAL-FLUID IN RABBITS

被引:25
作者
TRENQUE, T [1 ]
LAMIABLE, D [1 ]
VISTELLE, R [1 ]
MILLART, H [1 ]
LEPERRE, A [1 ]
CHOISY, H [1 ]
机构
[1] UFR PHARM,PHARMACOL LAB,F-51096 REIMS,FRANCE
关键词
DEXAMETHASONE; BETAMETHASONE; PLASMA; CSF; RABBIT;
D O I
10.1111/j.1472-8206.1994.tb00822.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The two diastereoisomers dexamethasone (DXM) and betamethasone (BTM) were infused at two different doses (2, 10 mg.kg(-1)) in anesthetized rabbits. Samples of plasma and cerebrospinal fluid were collected over a 180-min period. Steroid concentrations were measured by high performance liquid chromatography. The terminal half life (85.7 +/- 20.8 min and 102.2 +/- 29.6 min for DXM; 117.6 +/- 19.8 min and 118.5 +/- 15.8 min for BTM) and the mean residence time (121.4 +/- 27.7 min and 146.1 +/- 41.3 min for DXM; 168.6 +/- 28.1 min and 172.2 +/- 20.6 min for BTM) were unchanged between the doses. Dose-dependent changes in the area under the curve normalized by the dose, then volume distribution and clearance were observed. The average percentage of DXM and BTM bound to plasma proteins were 78.1 +/- 11.5% and 88.3 +/- 5.1% respectively at the lower dose, and decreased significantly with 10 mg.kg(-1). DXM appeared more rapidly in the CSF, the highest concentrations of DXM were obtained within 15 min after the end of the injection. The CSF levels were lower than that of plasma unbound and the passage through the blood-brain barrier was saturable. These results will complicate pharmacokinetic and pharmacodynamic analysis.
引用
收藏
页码:430 / 436
页数:7
相关论文
共 35 条
[1]  
ARENDT MR, 1983, J PHARMACOL EXP THER, V223, P98
[2]   PHARMACOKINETICS, CENTRAL NERVOUS-SYSTEM UPTAKE, AND LIPID SOLUBILITY OF PROPRANOLOL, ACEBUTOLOL, AND SOTALOL [J].
ARENDT, RM ;
GREENBLATT, DJ ;
DEJONG, RH ;
BONIN, JD ;
ABERNETHY, DR .
CARDIOLOGY, 1984, 71 (06) :307-314
[3]   DIFFERENCES IN CEREBROSPINAL-FLUID PENETRATION OF CORTICOSTEROIDS - POSSIBLE RELATIONSHIP TO THE PREVENTION OF MENINGEAL LEUKEMIA [J].
BALIS, FM ;
LESTER, CM ;
CHROUSOS, GP ;
HEIDEMAN, RL ;
POPLACK, DG .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (02) :202-207
[4]  
BARTH J, 1992, INT J CLIN PHARM TH, V30, P317
[5]   DOSE-DEPENDENT PHARMACOKINETICS OF PREDNISOLONE IN NORMAL AND ADRENALECTOMIZED RATS [J].
BOUDINOT, FD ;
JUSKO, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1986, 14 (05) :453-467
[6]   ESTRIP, A BASIC COMPUTER-PROGRAM FOR OBTAINING INITIAL POLYEXPONENTIAL PARAMETER ESTIMATES [J].
BROWN, RD ;
MANNO, JE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (12) :1687-1691
[7]  
CARROLL BJ, 1976, ARCH GEN PSYCHIAT, V33, P1039
[8]   PLASMA DEXAMETHASONE CONCENTRATIONS AND CORTISOL SUPPRESSION RESPONSE IN PATIENTS WITH ENDOGENOUS-DEPRESSION [J].
CARROLL, BJ ;
SCHROEDER, K ;
MUKHOPADHYAY, S ;
GREDEN, JF ;
FEINBERG, M ;
RITCHIE, J ;
TARIKA, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (03) :433-437
[9]  
FELL P J, 1972, Clinical Endocrinology, V1, P65, DOI 10.1111/j.1365-2265.1972.tb00378.x
[10]   MODELING THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DEXAMETHASONE IN DEPRESSED-PATIENTS [J].
GUPTA, SK ;
RITCHIE, JC ;
ELLINWOOD, EH ;
WIEDEMANN, K ;
HOLSBOER, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (01) :51-55